Oruka Therapeutics, Inc. (ORKA) stock
ORKANasdaqPharmaceutical PreparationsFiscal year ends December 31
$96.32−2.92 (-2.94%)
Close on Nov 17, 2026Market cap $6.38BP/E –Yield –
Oruka Therapeutics EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Oruka Therapeutics's EV/EBITDA was 0.7× on Oct 31, 2011.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2011 | Oct 31, 2011 | 0.7× | – |
See a number that looks wrong?